TR200100642T2 - Helioksantin ve analogları ile hepatit B virüsü ve flavivirüsün engellenmesi ve tedavisi. - Google Patents

Helioksantin ve analogları ile hepatit B virüsü ve flavivirüsün engellenmesi ve tedavisi.

Info

Publication number
TR200100642T2
TR200100642T2 TR2001/00642T TR200100642T TR200100642T2 TR 200100642 T2 TR200100642 T2 TR 200100642T2 TR 2001/00642 T TR2001/00642 T TR 2001/00642T TR 200100642 T TR200100642 T TR 200100642T TR 200100642 T2 TR200100642 T2 TR 200100642T2
Authority
TR
Turkey
Prior art keywords
virus
hepatitis
helioxanthin
treatment
flavivirus
Prior art date
Application number
TR2001/00642T
Other languages
English (en)
Inventor
Cheng Yung-Chi
Chou Chen-Kung
Fu Lei
Kuo Yueh-Hsiung
Yeh Sheau-Farn
Zhu Juliang
Zhu Yonglian
Original Assignee
Yale University
National Taiwan University
National Yang Ming University
Veterans General Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University, National Taiwan University, National Yang Ming University, Veterans General Hospital filed Critical Yale University
Publication of TR200100642T2 publication Critical patent/TR200100642T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Bu bulus, Helioksantin ve analoglari gibi anti-viral ilaçlara iliskindir. Bu bulus bilesikleri, Hepatit B virüsü (HBV), Hepatit C virüsü (HCV), Sari Humma, Dang Virüsü, Japon Ensefaliti, Bati Nil virüsü ve iliskili flavivirüslerin tedavisi için tek basina ya da diger ilaçlar ile bir arada kullanilabilmektedir. Ilave olarak, bu bulusa göre bilesikler, virüs enfeksiyonuna sekonder hepatomanin yanisira virüs enfeksiyonuna sekonder olan diger enfeksiyonlar ya da hastalik hallerinin engellenmesi için kullanilabilmektedir.
TR2001/00642T 1998-08-25 1999-08-23 Helioksantin ve analogları ile hepatit B virüsü ve flavivirüsün engellenmesi ve tedavisi. TR200100642T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9802598P 1998-08-25 1998-08-25

Publications (1)

Publication Number Publication Date
TR200100642T2 true TR200100642T2 (tr) 2001-07-23

Family

ID=22266367

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00642T TR200100642T2 (tr) 1998-08-25 1999-08-23 Helioksantin ve analogları ile hepatit B virüsü ve flavivirüsün engellenmesi ve tedavisi.

Country Status (10)

Country Link
US (1) US6306899B1 (tr)
EP (1) EP1107961A4 (tr)
JP (1) JP2002523408A (tr)
CN (1) CN1342156A (tr)
AU (1) AU5578099A (tr)
BR (1) BR9913333A (tr)
CA (1) CA2341540A1 (tr)
MX (1) MXPA01001777A (tr)
TR (1) TR200100642T2 (tr)
WO (1) WO2000010991A1 (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023432A1 (en) * 1998-10-20 2000-04-27 Hughes, E., John, L. Therapeutic compounds and methods
US7425437B2 (en) 1999-11-26 2008-09-16 Crucell Holland B.V. Vaccines against West Nile Virus
US7877273B2 (en) * 2002-01-08 2011-01-25 Fredric David Abramson System and method for evaluating and providing nutrigenomic data, information and advice
US20030215917A1 (en) * 2002-04-04 2003-11-20 Mingjun Huang Assay for evaluation of activity of compounds against HCV using a novel detection system in the HCV replicon
KR20050005442A (ko) * 2002-04-12 2005-01-13 아칠리온 파르마세우티칼스 인코포레이티드 β-Ｌ-플루오로-2',3'-디데히드로사이티딘(β-Ｌ-ＦＤ4Ｃ)의합성 방법
TWI293248B (en) * 2002-05-23 2008-02-11 Nat Health Research Institutes Anti-virus compounds
US7754718B2 (en) * 2004-05-05 2010-07-13 Yale University Antiviral helioxanthin analogs
SE527214C2 (sv) 2004-06-01 2006-01-24 Flexlink Components Ab Arrangemang och metod för räckesinställning vid en transportör
CA2591665C (en) 2004-12-20 2015-05-05 Crucell Holland B.V. Binding molecules capable of neutralizing west nile virus and uses thereof
AU2006245734C1 (en) * 2005-05-12 2012-05-24 Crucell Holland B.V. Host cell specific binding molecules capable of neutralizing viruses and uses thereof
EP1893645A1 (en) * 2005-06-23 2008-03-05 Crucell Holland B.V. Optimization of west nile virus antibodies
CA2654712C (en) 2006-06-06 2015-05-05 Crucell Holland B.V. Human binding molecules having killing activity against staphylococci and uses thereof
US20100068147A1 (en) * 2006-10-05 2010-03-18 Agency for Science , Technology and Research Dengue diagnosis and treatment
TWI399214B (zh) * 2011-05-04 2013-06-21 Univ China Medical 製備奈米多醣體複合粒子之方法及其用途
JP6041877B2 (ja) 2011-08-12 2016-12-14 サザン リサーチ インスティテュート キナゾリノン類似体及び特定のウイルス感染症の治療又は予防へのキナゾリノン類似体の使用
CN103381162A (zh) * 2013-07-04 2013-11-06 丁圣雨 Chukrasone A在治疗登革病毒感染药物中的应用
CN104804014B (zh) * 2015-03-27 2017-03-15 云南民族大学 一种Icetexane型二萜二聚体类化合物及其制备方法和应用
CN114989131B (zh) * 2022-05-30 2023-10-24 云南大学 N’-(2-(苯并[1,3]二氧戊烷-5-基)酰基)芳酰肼类化合物及其合成和用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486445A (en) 1983-01-12 1984-12-04 E. I. Du Pont De Nemours And Company Justicidin insecticidal and antiviral compounds
ES8705837A1 (es) * 1985-01-10 1987-05-16 Tanabe Seiyaku Co Un procedimiento para la preparacion de derivados de naftaleno.
JPS61215394A (ja) 1985-03-19 1986-09-25 Taisho Pharmaceut Co Ltd ナフタレン型リグナンラクトンン中間体の製造方法
US4673575A (en) 1985-04-26 1987-06-16 Fox Chase Cancer Center Composition, pharmaceutical preparation and method for treating viral hepatitus
US4937074A (en) 1988-03-29 1990-06-26 Fox Chase Cancer Center Method of treating retrovirus infection
US5015739A (en) 1988-04-22 1991-05-14 Schering Corporation Processes for preparation of cyclopentyl purine derivatives
US5817638A (en) 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US4999428A (en) 1989-04-14 1991-03-12 Schering Corporation Process for preparing cyclopentyl purine derivatives
US5688778A (en) 1989-05-15 1997-11-18 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Nucleoside analogs
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5595739A (en) 1993-05-07 1997-01-21 Abbott Laboratories Hepatitis B virus mutants, reagents and methods for detection
TW374087B (en) 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
WO1995001950A1 (fr) * 1993-07-06 1995-01-19 Tsumura & Co. Derive de tetrahydronaphtalene, son procede de production et remede contre une infection a retrovirus le contenant comme ingredient actif
JP3769737B2 (ja) 1994-03-30 2006-04-26 味の素株式会社 シクロプロパン誘導体及びその製造法
GB9422946D0 (en) 1994-11-14 1995-01-04 Univ Salamanca Antineoplastic cyclolignan derivatives
AU4677496A (en) * 1995-02-21 1996-09-11 Takeda Chemical Industries Ltd. Use of helioxanthin as an enhancer of cell differentiation inducing factors
JPH09227568A (ja) * 1996-02-28 1997-09-02 Takeda Chem Ind Ltd ヘリオキサンチンの製造法
US5891874A (en) 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
US5821242A (en) 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
WO1998007437A1 (en) 1996-08-16 1998-02-26 Hepaguard Co., Ltd. PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B COMPRISING EXTRACT OF PHYLLANTHUS USSURIENSIS AND/OR $i(PHYLLANTHUS URINARIA)
ID18046A (id) * 1996-08-20 1998-02-19 Takeda Chemical Industries Ltd Senyawa siklik campuran, pembuatan dan penngunaannya.
WO1998049155A1 (en) * 1997-04-25 1998-11-05 Takeda Chemical Industries, Ltd. Cell differentiation inducing amide derivatives, their production and use

Also Published As

Publication number Publication date
JP2002523408A (ja) 2002-07-30
EP1107961A4 (en) 2002-01-30
MXPA01001777A (es) 2002-06-04
CA2341540A1 (en) 2000-03-02
EP1107961A1 (en) 2001-06-20
CN1342156A (zh) 2002-03-27
BR9913333A (pt) 2001-05-15
AU5578099A (en) 2000-03-14
WO2000010991A1 (en) 2000-03-02
US6306899B1 (en) 2001-10-23

Similar Documents

Publication Publication Date Title
TR200100642T2 (tr) Helioksantin ve analogları ile hepatit B virüsü ve flavivirüsün engellenmesi ve tedavisi.
EA200300819A1 (ru) Производные нуклеозидов в качестве ингибиторов рнк-зависимой рнк вирусной полимеразы
DK1066247T3 (da) Inhibitorer af serinproteaser, især hepatitis C virus NS3 protease
MXPA04012779A (es) Profarmacos de 2'- y 3'-nucleosido para tratar infecciones por flaviviridae.
SG161315A1 (en) Compounds and methods for the treatment or prevention of flavivirus infections
MY141594A (en) 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
UA66767C2 (uk) Інгібітори серин-протеаз, фармацевтична композиція, спосіб інгібування активності та спосіб лікування або профілактики вірусної інфекції гепатиту с
ATE541844T1 (de) Antivirale verbindungen
PT1268519E (pt) Inibidores de serina protease, particularmente protease ns3 do virus da hepatite c
DE69233770D1 (de) Chimäre und/oder wachstumgehemmte Flaviviren
WO2004002422A3 (en) 2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
TW200500373A (en) 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
BRPI0515596A (pt) composição farmacêutica usada para o tratamento e/ou prevenção de hcv, e, métodos de inibir rna polimerase ns5b de hepatite c de tratar ou prevenir infecção por hepatite c em um mamìfero
EA200700243A1 (ru) Способы лечения гепатита с
WO2004011478A3 (en) Anti-viral 7-deaza d-nucleosides and uses thereof
GT200600262A (es) Uso de la sangliferina en el hcv (virus de la hepatitis "c")
EP1399163A4 (en) COMPOUNDS, METHODS AND COMPOSITIONS FOR THE TREATMENT OF BOVINE VIRAL DIARRHEA (VBVD) INFECTION AND HEPATITIS C (HCV) VIRUS INFECTION
NO20034878L (no) Antivirale forbindelser
WO2006121467A3 (en) Tetrahydrocarbazole derivatives for treating flaviridae viruses
WO2004112720A3 (en) Antiviral compositions and methods of using the same
WO2005010143A3 (en) Methods of treatment and disgnosis using modulators of virus-induced cellular gene sequences
MXPA02011969A (es) Metodos para el tratamiento de padecimientos virales con il-18 y combinaciones de il-18.
AP2001002181A0 (en) Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis C virus and other toga viruses.
WO2000015210A3 (en) Use of mycophenol acid and its derivatives for the treatment of virus diseases
TW200738707A (en) Anti-viral compounds